Takeda Pharmaceutical Co. has agreed to pay up to $2.4 billion to resolve bladder cancer claims tied to its Type 2 diabetes drug Actos. The settlement will compensate an estimated 10,000 cla... Read more
In another Actos case, a Philadelphia state court jury, ordered Takeda Pharmaceuticals to pay more than $2 million for failing to warn doctors that its diabetes drug Actos could cause bladde... Read more
A Louisiana federal judge has reduced the $9 billion punitive damages award against Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. over the diabetes drug Actos to $36.8 million. U.S.... Read more
The first federal Actos trial is underway in Lafayette, La., before Judge Rebecca Doherty. Following jury selection, which took place the week before, the trial started on Feb. 4 and was ong... Read more
In the first of more than 3,000 Actos bladder cancer lawsuits to go trial, a jury returned a $6.5 million verdict last month against Takeda Pharmaceuticals American Inc. in favor of Jack Coo... Read more
A doctor under contract with Takeda Pharmaceuticals claims in a whistleblower lawsuit that she met with resistance from her superiors at Takeda when she attempted to report Actos bladder can... Read more
In June 2011, the FDA warned the public that Actos usage for more than one year may be associated with an increased risk of bladder cancer. Actos, manufactured by Takeda, is in a class of in... Read more
There have been hundreds of lawsuits filed against Takeda Pharmaceuticals Co. Ltd., the maker of Actos, the world’s best-selling diabetes drug. Evidence continues to mount indicating that ta... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.